0001209191-11-039505.txt : 20110714
0001209191-11-039505.hdr.sgml : 20110714
20110714150416
ACCESSION NUMBER: 0001209191-11-039505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110713
FILED AS OF DATE: 20110714
DATE AS OF CHANGE: 20110714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER KENNETH S
CENTRAL INDEX KEY: 0001046336
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11967883
MAIL ADDRESS:
STREET 1: C/O ECOSCIENCE CORP
STREET 2: 10 ALVIN COURT
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-07-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001046336
BOGER KENNETH S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02176
0
1
0
0
SVP & General Counsel
Common Stock
2011-07-13
4
M
0
7334
18.75
A
120333
D
Common Stock
2011-07-13
4
S
0
7334
51.92
D
112999
D
Common Stock
5021
I
401(k)
Common Stock
174167
I
Trustee of Trusts
Stock Option
18.75
2011-07-13
4
M
0
7334
0.00
D
2011-09-23
Common Stock
7334
36667
D
Stock Option
51.75
2011-07-13
4
A
0
30500
0.00
A
2011-10-13
2021-07-12
Common Stock
30500
30500
D
Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $51.92 (range $51.51 to $52.25).
Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer).
Fully vested.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011.
Valerie L. Andrews, Attorney-In-Fact
2011-07-14